ArticleScientific reports2026
Optimization of ultrasound extraction of phlorotannin rich extract from Dictyopteris justii with tyrosinase Inhibition.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The growing demand for safe and effective natural ingredients in cosmetic formulations has prompted research into marine-derived compounds, particularly phlorotannins from brown algae. These compounds exhibit diverse bioactivities, including tyrosinase inhibition, which is relevant for the treatment of skin hyperpigmentation disorders. This study aimed to optimize the ultrasound-assisted extraction (UAE) of phlorotannins from the brown macroalga Dictyopteris justii and to evaluate the in vitro tyrosinase inhibitory activity of the resulting extract. A Box-Behnken design was employed to optimize the extraction parameters: ethanol concentration, solid-to-liquid ratio, temperature, and time. Total phlorotannin content (TPhC) was quantified using the DMBA colorimetric method, and the optimized extract was evaluated for tyrosinase inhibitory activity using a commercial colorimetric assay. The IC₅₀ of the extract was determined and compared with kojic acid. The optimal extraction conditions were identified as 70% ethanol, a 1:10 solid-to-liquid ratio, 25 °C, and 20 min. Under these conditions, the TPhC reached 2.874 ± 0.069 mg phloroglucinol equivalents per gram of dry extract, with a 9% extraction yield. Chromatographic analysis suggests the presence of hydroxypentafuhalol-B in the extract.The optimized extract showed significant tyrosinase inhibitory activity with an IC₅₀ of 0.51 mg/mL, compared to 46.61 µg/mL for kojic acid. This study demonstrates the successful optimization of UAE for obtaining a phlorotannin-rich extract from D. justii with reproducible extraction efficiency and potent tyrosinase inhibition. These findings support the potential application of D. justii extracts in the development of cosmetic products targeting hyperpigmentation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.